Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
2023 Spotlight
Special Series
Conference Correspondent
ASCO 2023 - Breast Cancer
LBCL 2022 - Year in Review
NSCLC IO 2022 - Midyear Review
ASCO 2022 - Wrap Up
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Women's Health
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
2023 Spotlight
Special Series
Conference Correspondent
ASCO 2023 - Breast Cancer
LBCL 2022 - Year in Review
NSCLC IO 2022 - Midyear Review
ASCO 2022 - Wrap Up
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Women's Health
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Videos
Relapsed or Refractory FL: Best Practices for Active Surveillance & Reinforcement of Management Plans
FEATURING:
Tycel J. Phillips, MD
;
Peg Rummel, MHA, RN, OCN, NE-BC
;
Andrew D. Zelenetz, MD, PhD
October 4, 2022
Interview with the Innovators
Watch Video
Updates on 1L Maintenance Therapy with PARP Inhibitors for Advanced Ovarian Cancer
FEATURING:
David O’Malley, MD
October 3, 2022
Rapid Reactions
Watch Video
Predicting High-Risk Disease Using Progression of Disease in 24 Months (POD24) and the Key Role of Repeat Biopsy to Exclude the Diagnosis of Transformation to a High-Grade Lymphoma in Patients with Relapsed Follicular Lymphoma
FEATURING:
Tycel J. Phillips, MD
;
Peg Rummel, MHA, RN, OCN, NE-BC
;
Andrew D. Zelenetz, MD, PhD
September 23, 2022
Interview with the Innovators
Watch Video
Broadening the Variety of Candidate Therapies for R/R Follicular Lymphoma Allows Optimal Personalized Rx Choice, While Patient-Directed Education Helps Attain Greatest Clinical Benefit
FEATURING:
Tycel J. Phillips, MD
;
Peg Rummel, MHA, RN, OCN, NE-BC
;
Andrew D. Zelenetz, MD, PhD
September 19, 2022
Interview with the Innovators
Watch Video
Criteria Used to Guide Treatment Decisions and Choice of Therapeutic Agents in Patients with Relapsed or Refractory Follicular Lymphoma
FEATURING:
Tycel J. Phillips, MD
;
Peg Rummel, MHA, RN, OCN, NE-BC
;
Andrew D. Zelenetz, MD, PhD
September 12, 2022
Interview with the Innovators
Watch Video
Specific Dysregulation of B-Cell Signaling in Follicular Lymphoma and Its Role in the Initiation and Progression of This Malignancy
FEATURING:
Tycel J. Phillips, MD
;
Peg Rummel, MHA, RN, OCN, NE-BC
;
Andrew D. Zelenetz, MD, PhD
September 6, 2022
Interview with the Innovators
Watch Video
Spectrum of Symptoms in Patients Newly Diagnosed with Follicular Lymphoma and the Role of Optimal Coordination of Care at Initial Presentation
FEATURING:
Tycel J. Phillips, MD
;
Peg Rummel, MHA, RN, OCN, NE-BC
;
Andrew D. Zelenetz, MD, PhD
August 31, 2022
Interview with the Innovators
Watch Video
Epidemiology and expected survivorship in follicular lymphoma and lack of reliable long-term outcome predictors at disease presentation
FEATURING:
Tycel J. Phillips, MD
;
Peg Rummel, MHA, RN, OCN, NE-BC
;
Andrew D. Zelenetz, MD, PhD
August 23, 2022
Interview with the Innovators
Watch Video
Underserved Patients with HER2-Positive mBC
FEATURING:
Neil M. Iyengar, MD
July 11, 2022
Rapid Reactions
Watch Video
Page 2 of 17
1
2
3
4
5
